<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2012.1126</article-id>
<article-id pub-id-type="publisher-id">ijmm-30-06-1287</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP<sub>3</sub>R in the stomach and kidney</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>FUJIMOTO</surname><given-names>TAKAHIRO</given-names></name><xref rid="af1-ijmm-30-06-1287" ref-type="aff"><sup>1</sup></xref><xref rid="af2-ijmm-30-06-1287" ref-type="aff"><sup>2</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>SHIRASAWA</surname><given-names>SENJI</given-names></name><xref rid="af1-ijmm-30-06-1287" ref-type="aff"><sup>1</sup></xref><xref rid="af2-ijmm-30-06-1287" ref-type="aff"><sup>2</sup></xref><xref ref-type="corresp" rid="c1-ijmm-30-06-1287"/></contrib></contrib-group>
<aff id="af1-ijmm-30-06-1287">
<label>1</label>Department of Cell Biology, Faculty of Medicine and</aff>
<aff id="af2-ijmm-30-06-1287">
<label>2</label>Central Research Institute for Advanced Molecular Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, 
<country>Japan</country></aff>
<author-notes>
<corresp id="c1-ijmm-30-06-1287">Correspondence to: Professor Senji Shirasawa, Department of Cell Biology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan, E-mail: <email>sshirasa@fukuoka-u.ac.jp</email></corresp></author-notes>
<pub-date pub-type="collection">
<month>12</month>
<year>2012</year></pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>09</month>
<year>2012</year></pub-date>
<volume>30</volume>
<issue>6</issue>
<fpage>1287</fpage>
<lpage>1293</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>06</month>
<year>2012</year></date>
<date date-type="accepted">
<day>20</day>
<month>08</month>
<year>2012</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2012, Spandidos Publications</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p><italic>KRAS</italic>-induced actin-interacting protein (KRAP), originally identified as one of the deregulated genes expressed in colorectal cancer, participates under physiological conditions in the regulation of systemic energy homeostasis and of the exocrine system. We have recently found that KRAP is a molecule associated with inositol 1,4,5-trisphosphate receptor (IP<sub>3</sub>R) and is critical for the proper subcellular localization of IP<sub>3</sub>R in the liver and the pancreas. However, the expression of KRAP and its precise function in other tissues remain elusive. In this study, we aimed to identify the KRAP-expressing cells in mouse stomach and kidneys and to examine the relevance of KRAP expression in the regulation of IP<sub>3</sub>R localization in these tissues. In the stomach, double immunohistochemical staining for KRAP and IP<sub>3</sub>R demonstrated that KRAP was expressed along with the apical regions in the mucous cells and the chief cells, and IP<sub>3</sub>R3 was dominantly co-localized with KRAP in these cells. Furthermore, IP<sub>3</sub>R2 was also co-localized with IP<sub>3</sub>R3 in the chief cells. It is of note that the proper localization of IP<sub>3</sub>R3 and IP<sub>3</sub>R2 in the chief cells and of IP<sub>3</sub>R3 in the mucous cells were significantly abrogated in <italic>KRAP</italic>-deficient mice. In the kidneys, KRAP was expressed in both the apical and the basal regions of the proximal tubular cells. Intriguingly, <italic>KRAP</italic> deficiency abrogated the localization of IP<sub>3</sub>R1 in the proximal tubular cells. Finally, co-immunoprecipitation study in the stomachs and the kidneys validated the physical association of KRAP with IP<sub>3</sub>Rs. These findings demonstrate that KRAP physically associates with IP<sub>3</sub>Rs and regulates the proper localization of IP<sub>3</sub>Rs in the mucous cells and the chief cells of the stomach and in the proximal tubular cells of the kidneys.</p></abstract>
<kwd-group>
<kwd>RAS-induced actin-interacting protein</kwd>
<kwd>inositol 1,4,5-trisphosphate receptor</kwd>
<kwd>immunohistochemical staining</kwd>
<kwd>protein-protein interaction</kwd>
<kwd>stomach</kwd>
<kwd>kidney</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Three inositol 1,4,5-trisphosphate receptor (IP<sub>3</sub>R) subtypes, IP<sub>3</sub>R1, IP<sub>3</sub>R2, and IP<sub>3</sub>R3, are differentially expressed among tissues (<xref rid="b1-ijmm-30-06-1287" ref-type="bibr">1</xref>&#x02013;<xref rid="b5-ijmm-30-06-1287" ref-type="bibr">5</xref>) and function as the Ca<sup>2&#x0002B;</sup> release channel on endoplasmic reticulum membranes (<xref rid="b6-ijmm-30-06-1287" ref-type="bibr">6</xref>&#x02013;<xref rid="b10-ijmm-30-06-1287" ref-type="bibr">10</xref>). IP<sub>3</sub>R is regulated by many intracellular modulators, phosphorylation by kinases, and associated proteins (<xref rid="b11-ijmm-30-06-1287" ref-type="bibr">11</xref>&#x02013;<xref rid="b15-ijmm-30-06-1287" ref-type="bibr">15</xref>).</p>
<p><italic>KRAS</italic>-induced actin-interacting protein (KRAP) was originally identified as one of the deregulated expression gene in the colorectal cancer cell line, HCT116 (<xref rid="b16-ijmm-30-06-1287" ref-type="bibr">16</xref>). The previous studies using <italic>KRAP</italic>-knockout (<italic>KRAP</italic>-KO) mice demonstrate that KRAP participates in the regulation of systemic energy homeostasis (<xref rid="b17-ijmm-30-06-1287" ref-type="bibr">17</xref>) and of exocrine system (<xref rid="b18-ijmm-30-06-1287" ref-type="bibr">18</xref>). Among the adult mouse tissues, KRAP is ubiquitously expressed, with high levels in the pancreas, liver, and brown adipose tissues, and KRAP localizes in the restricted apical regions of the liver parenchymal cells and of the pancreatic exocrine acinar cells (<xref rid="b19-ijmm-30-06-1287" ref-type="bibr">19</xref>). Our recent findings indicate that KRAP associates with IP<sub>3</sub>R to regulate its proper subcellular localization in the mouse liver and the pancreas (<xref rid="b20-ijmm-30-06-1287" ref-type="bibr">20</xref>) as well as in immortalized cultured cell lines (<xref rid="b21-ijmm-30-06-1287" ref-type="bibr">21</xref>). Despite these advances, it remains largely unknown which cell types express KRAP among the other tissues including stomach and kidneys.</p>
<p>Herein, we performed immunohistological analysis and identified the exact KRAP-expressing cells in the stomach and the kidneys, and demonstrated that KRAP plays critical role in the regulation of the precise subcellular localization of IP<sub>3</sub>R in the mucous and the chief cells of the stomach and in the proximal tubular cells of the kidneys.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Animals</title>
<p>All animals used in this study were treated in accordance with the guidelines of Fukuoka University. KRAP-knockout mice were generated as described previously (<xref rid="b17-ijmm-30-06-1287" ref-type="bibr">17</xref>).</p></sec>
<sec>
<title>Immunohistochemical staining</title>
<p>Immunohistochemical staining was performed as described previously (<xref rid="b19-ijmm-30-06-1287" ref-type="bibr">19</xref>,<xref rid="b20-ijmm-30-06-1287" ref-type="bibr">20</xref>). Specific signals were detected by using rabbit polyclonal anti-KRAP antibody (<xref rid="b19-ijmm-30-06-1287" ref-type="bibr">19</xref>), mouse monoclonal anti-ZO-1 antibody (ZYMED), mouse monoclonal anti-IP<sub>3</sub>R3 antibody (610313) from BD Transduction Laboratories, rabbit polyclonal anti-IP<sub>3</sub>R2 antibody (AB3000) from Millipore, and rabbit polyclonal anti-IP<sub>3</sub>R1 antibody (ab5840) from Abcam.</p></sec>
<sec>
<title>Immunoprecipitations and western blotting</title>
<p>Immunoprecipitations and western blotting were performed as described previously (<xref rid="b19-ijmm-30-06-1287" ref-type="bibr">19</xref>,<xref rid="b20-ijmm-30-06-1287" ref-type="bibr">20</xref>).</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Localization of KRAP protein in the adult mouse stomach</title>
<p>To examine the cellular distribution of KRAP protein in the adult mouse tissues, we performed immunohistochemical staining by using anti-KRAP antibody. In the stomach, strong KRAP immunoreactivity was restricted to the pit regions of gastric glands (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1A</xref>), whereas significant expression of KRAP was not detected in the muscularis mucosae beneath the gastric glands (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1A, arrows</xref>). The specificity of KRAP expression in the stomach was confirmed by using <italic>KRAP</italic>-KO tissue as a control (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1B</xref>). In the pit region of the gastric gland, where columnar surface mucous cells mainly exist (<xref rid="b22-ijmm-30-06-1287" ref-type="bibr">22</xref>), KRAP was localized beneath the apical membranes of the mucous cells (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1C</xref>). In the base region of the gastric glands, where zymogenic chief cells mainly exist, coronal plane of deeper gastric glands showed that KRAP was restricted to the apical regions of the chief cells (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1D, arrowheads</xref>), whereas KRAP was not detected in the parietal cells (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1D, asterisks</xref>). The distinction between the chief and the parietal cells was validated by ZO-1 staining as described (<xref rid="b23-ijmm-30-06-1287" ref-type="bibr">23</xref>), indicating that KRAP was expressed in the ZO-1-positive chief cells but not in the ZO-1-negative parietal cells (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1E</xref>).</p></sec>
<sec>
<title>KRAP co-localized with IP<sub>3</sub>R in the stomach</title>
<p>Since we previously reported that KRAP associates with particular subtypes of IP<sub>3</sub>R in the liver and the pancreas (<xref rid="b20-ijmm-30-06-1287" ref-type="bibr">20</xref>), we examined whether KRAP in the stomach is also co-localized with IP<sub>3</sub>R. Double-immunostaining of the stomach for KRAP and IP<sub>3</sub>R3 revealed that KRAP was co-localized with IP<sub>3</sub>R3 in the apical regions of both the chief cells (<xref rid="f2-ijmm-30-06-1287" ref-type="fig">Fig. 2A, arrows</xref>) and the mucous cells (<xref rid="f2-ijmm-30-06-1287" ref-type="fig">Fig. 2B, arrows</xref>). Of note, IP<sub>3</sub>R2 co-existed with IP<sub>3</sub>R3 in the chief cells (<xref rid="f2-ijmm-30-06-1287" ref-type="fig">Fig. 2C, arrow</xref>) but not in the parietal cells (<xref rid="f2-ijmm-30-06-1287" ref-type="fig">Fig. 2C, asterisks</xref>). Furthermore, IP<sub>3</sub>R2 was not detected in the mucous cells (<xref rid="f2-ijmm-30-06-1287" ref-type="fig">Fig. 2D, arrows</xref>). These results indicated that KRAP was co-localized with IP<sub>3</sub>R2 and IP<sub>3</sub>R3 in the chief cells and with IP<sub>3</sub>R3 in the mucous cells.</p></sec>
<sec>
<title>Impaired localization of IP<sub>3</sub>R in the KRAP-deficient chief cells and the mucous cells</title>
<p>We addressed the functional relevance of KRAP to the proper localization of IP<sub>3</sub>R by using <italic>KRAP</italic>-KO mice. IP<sub>3</sub>R3 was located in the apical region of the chief cells (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3A, arrow</xref>) and of the mucous cells (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3C, arrows</xref>) in the wild-type (WT) mouse stomach, whereas the restricted localization of IP<sub>3</sub>R3 appeared to be diminished in the <italic>KRAP</italic>-KO stomach (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3B, arrow; 3D, arrows</xref>). Furthermore, IP<sub>3</sub>R2 was detected in both the chief cells (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3E, arrows</xref>) and the parietal cells (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3E, asterisks</xref>) in the WT stomach, whereas the localization of IP<sub>3</sub>R2 in the <italic>KRAP</italic>-KO stomach was impaired in the chief cells (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3F, arrows</xref>) but not in the parietal cells (<xref rid="f3-ijmm-30-06-1287" ref-type="fig">Fig. 3F, asterisks</xref>). Thus, KRAP plays critical role in the regulation of the proper localization of IP<sub>3</sub>R2 and IP<sub>3</sub>R3 in the chief cells and of IP<sub>3</sub>R3 in the mucous cells.</p></sec>
<sec>
<title>KRAP expression and its contribution to the localization of IP<sub>3</sub>R1 in the proximal tubules of the mouse kidney</title>
<p>To examine the cellular distribution of KRAP protein in the adult mouse kidneys, we performed immunohistochemical staining by using anti-KRAP antibody. The specificities of the signals were validated by comparing the immunoreactivities of WT and <italic>KRAP</italic>-KO mouse tissues. In the WT kidneys, intense immunoreactivities were observed in the renal proximal tubules (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4A</xref>) but not in the renal distal tubules (data not shown). On the other hand, significant immunoreactive signal was not detected in the proximal tubules in the <italic>KRAP</italic>-KO mice (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4B</xref>). Taken together, these results indicate that KRAP was exactly expressed in the proximal tubules. The proximal tubules were identified by the presence of the brush-border stained with phalloidin (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4A and B</xref>). Immunostaining in the proximal region showed that KRAP was accumulated beneath the brush-border (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4A, arrows</xref>) and KRAP was also detected in the basolateral actin bundles (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4A, arrowheads</xref>). We next examined which subtypes of IP<sub>3</sub>R, IP<sub>3</sub>R1, IP<sub>3</sub>R2, and IP<sub>3</sub>R3, expressed in the proximal tubular cells, revealing that IP<sub>3</sub>R1 (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4C</xref>) but not IP<sub>3</sub>R 2 or IP<sub>3</sub>R3 (data not shown) was detected in the beneath the brush-border and in the basolateral actin bundles. Finally, we addressed the functional relevance of KRAP expression in the proximal tubular cells to the regulation of IP<sub>3</sub>R localization. It is of note that the restricted localization of IP<sub>3</sub>R1 detected in the WT mouse kidney (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4C</xref>) was disturbed in the <italic>KRAP</italic>-KO mouse kidney (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4D</xref>). Thus, KRAP plays critical role in the regulation of the proper localization of IP<sub>3</sub>R1 in the proximal tubular cells.</p></sec>
<sec>
<title>KRAP interacts with IP<sub>3</sub>R1 in the kidneys and with IP<sub>3</sub>R3 in the stomach</title>
<p>As described above, immunohistochemical signals for particular IP<sub>3</sub>R subtypes in the <italic>KRAP</italic>-KO mouse kidneys or the stomach were abrogated, leading us to check the expression levels of IP<sub>3</sub>R between the WT and <italic>KRAP</italic>-KO mouse tissues. Normal expression levels of IP<sub>3</sub>R1 and IP<sub>3</sub>R3 were detected in the <italic>KRAP</italic>-KO mouse kidney and the stomach, respectively, compared with the WT mouse tissues (<xref rid="f5-ijmm-30-06-1287" ref-type="fig">Fig. 5A</xref>), suggesting that mislocalizations but not deregulated expressions of IP<sub>3</sub>R occur in the <italic>KRAP</italic>-KO mouse kidneys and the stomach. Next, to examine the physical association of KRAP with IP<sub>3</sub>R, we performed co-immunoprecipitations by anti-KRAP antibody in the kidneys or the stomach, in which we could not evaluate the specific association of IP<sub>3</sub>R2 with KRAP due to lack of IP<sub>3</sub>R2-specific antibody available for western blotting. In the preparations from the WT mouse tissues, KRAP precipitates IP<sub>3</sub>R1 and IP<sub>3</sub>R3 in the kidney and the stomach, respectively (<xref rid="f5-ijmm-30-06-1287" ref-type="fig">Fig. 5B</xref>). The specificity of co-immunoprecipitations of IP<sub>3</sub>R was confirmed by using <italic>KRAP</italic>-KO mouse tissue as a control (<xref rid="f5-ijmm-30-06-1287" ref-type="fig">Fig. 5B</xref>). Thus, KRAP physically interacts with IP<sub>3</sub>R1 in the kidneys and with IP<sub>3</sub>R3 in the stomach.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In this study, we demonstrated that KRAP protein expression and the subcellular localization was restricted beneath the apical and/or basolateral membranes in specific cell types of the stomach and the kidneys, in which KRAP physically associated with particular IP<sub>3</sub>R subtype(s). In the <italic>KRAP</italic>-KO mouse stomach and the kidneys, the polarized localization of IP<sub>3</sub>R was impaired, indicating that KRAP plays critical roles in the regulation of the proper subcellular localization of IP<sub>3</sub>R in the stomach and the kidneys.</p>
<p>Notably, KRAP as well as IP<sub>3</sub>R3 proteins were polarized beneath the apical membranes facing the gastric gland lumen and were absent in the parietal cells (<xref rid="f1-ijmm-30-06-1287" ref-type="fig">Fig. 1</xref>), suggesting an association of these proteins with chief cell functions including pepsinogen secretion (<xref rid="b22-ijmm-30-06-1287" ref-type="bibr">22</xref>&#x02013;<xref rid="b24-ijmm-30-06-1287" ref-type="bibr">24</xref>). From this view point, KRAP expression and the localization beneath the apical membranes of the pancreatic acinar cells (<xref rid="b19-ijmm-30-06-1287" ref-type="bibr">19</xref>), another type of zymogen cells, may suggest a similar role for KRAP in the stomach and the pancreas. Considering the fact that KRAP physically interacts with IP<sub>3</sub>R to regulate its proper localization in these tissues, stomach (<xref rid="f2-ijmm-30-06-1287" ref-type="fig">Figs. 2</xref>, <xref rid="f3-ijmm-30-06-1287" ref-type="fig">3</xref> and <xref rid="f5-ijmm-30-06-1287" ref-type="fig">5</xref>) and pancreas (<xref rid="b20-ijmm-30-06-1287" ref-type="bibr">20</xref>), and that double-knockout of IP<sub>3</sub>R2 and IP<sub>3</sub>R3 in mice revealed a failure in secretory function in the pancreas (<xref rid="b25-ijmm-30-06-1287" ref-type="bibr">25</xref>), KRAP seems to be involved in the exocrine systems. Actually, the pancreatic acinar cells in <italic>KRAP</italic>-KO mice showed an increased amount of zymogen granules, although they seemed to maintain the proper physiological agonist-induced exocytosis (<xref rid="b18-ijmm-30-06-1287" ref-type="bibr">18</xref>). Thus, exact functional relevance of KRAP and its interaction with IP<sub>3</sub>R to the exocrine systems in the pancreas and the stomach should await future studies.</p>
<p>It is of note that KRAP was restricted to both the apical region and the basolateral region of the proximal tubular cells of the kidneys (<xref rid="f4-ijmm-30-06-1287" ref-type="fig">Fig. 4</xref>), and that KRAP physically associated with IP<sub>3</sub>R1 in the kidneys (<xref rid="f5-ijmm-30-06-1287" ref-type="fig">Fig. 5</xref>). Furthermore, our previous study showed that KRAP was distributed along the bile canaliculi of hepatocytes and underneath the apical membrane of pancreatic acinar cells (<xref rid="b19-ijmm-30-06-1287" ref-type="bibr">19</xref>). All these KRAP localizations in the distinct tissues examined are restricted to epithelial cell types bearing well-developed cell polarity, cell-cell junction and microvilli, where transports of various substances between epithelial cells and extracellular spaces, exocrine space or blood stream occur (<xref rid="b22-ijmm-30-06-1287" ref-type="bibr">22</xref>,<xref rid="b26-ijmm-30-06-1287" ref-type="bibr">26</xref>&#x02013;<xref rid="b28-ijmm-30-06-1287" ref-type="bibr">28</xref>). Since <italic>KRAP</italic>-KO mice displayed profound metabolic disorders after birth without developmental defects, and certain systemic inter-tissue dysregulations appeared to underlie the metabolic phenotypes (<xref rid="b17-ijmm-30-06-1287" ref-type="bibr">17</xref>), KRAP might play physiological roles in secretion and/or absorption functions after birth rather than in developmental events.</p>
<p>Renal proximal tubules serve the reabsorption of the bulk of substances filtered in the glomeruli and the excretion (<xref rid="b26-ijmm-30-06-1287" ref-type="bibr">26</xref>,<xref rid="b29-ijmm-30-06-1287" ref-type="bibr">29</xref>). These two opposite transports are accomplished by the coordinated action of ion channels and transporters located in the brush border membrane and basolateral membrane (<xref rid="b29-ijmm-30-06-1287" ref-type="bibr">29</xref>&#x02013;<xref rid="b31-ijmm-30-06-1287" ref-type="bibr">31</xref>). Thus, the polarized expression of these membrane proteins is crucial for the function of the proximal tubules. Based on the findings that KRAP protein possesses characteristic features like scaffolding protein, such as polarized localization and transporting of IP<sub>3</sub>R, potential functional relevance of KRAP to these processes would be suspected.</p>
<p>In conclusion, we identified the exact KRAP-expressing cells in the stomach and the kidneys, and found that KRAP physically associates with IP<sub>3</sub>R to regulate its proper subcellular localization <italic>in vivo</italic>. Considering the KRAP function as an IP<sub>3</sub>R regulator and the importance of KRAP in energy homeostasis <italic>in vivo</italic>, further research on the exact relevance of the association between KRAP and IP<sub>3</sub>R to the biological phenomena will lead to a better understanding of physiological metabolic processes.</p></sec></body>
<back>
<ack>
<p>This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities, a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. We thank Takami Danno and Yoko Tanaka for their technical assistance.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijmm-30-06-1287"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Danoff</surname><given-names>SK</given-names></name><name><surname>Schell</surname><given-names>MJ</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><name><surname>Ullrich</surname><given-names>A</given-names></name></person-group><article-title>Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues</article-title><source>Proc Natl Acad Sci USA</source><volume>89</volume><fpage>4265</fpage><lpage>4269</lpage><year>1992</year></element-citation></ref>
<ref id="b2-ijmm-30-06-1287"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>AH</given-names></name><name><surname>McPherson</surname><given-names>PS</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Aoki</surname><given-names>C</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><article-title>Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca<sup>2&#x0002B;</sup> release channels in rat brain</article-title><source>J Neurosci</source><volume>13</volume><fpage>3051</fpage><lpage>3063</lpage><year>1993</year></element-citation></ref>
<ref id="b3-ijmm-30-06-1287"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Yamamoto-Hino</surname><given-names>M</given-names></name><name><surname>Miyawaki</surname><given-names>A</given-names></name><name><surname>Furuichi</surname><given-names>T</given-names></name><name><surname>Mikoshiba</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name></person-group><article-title>Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression</article-title><source>FEBS Lett</source><volume>349</volume><fpage>191</fpage><lpage>196</lpage><year>1994</year></element-citation></ref>
<ref id="b4-ijmm-30-06-1287"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>CL</given-names></name><name><surname>Mignery</surname><given-names>GA</given-names></name><name><surname>S&#x000FC;dhof</surname><given-names>TC</given-names></name></person-group><article-title>Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3</article-title><source>J Biol Chem</source><volume>269</volume><fpage>28613</fpage><lpage>28619</lpage><year>1994</year></element-citation></ref>
<ref id="b5-ijmm-30-06-1287"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojcikiewicz</surname><given-names>RJ</given-names></name></person-group><article-title>Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types</article-title><source>J Biol Chem</source><volume>270</volume><fpage>11678</fpage><lpage>11683</lpage><year>1995</year></element-citation></ref>
<ref id="b6-ijmm-30-06-1287"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>T</given-names></name><name><surname>Ondriasov&#x000E1;</surname><given-names>E</given-names></name><name><surname>Ondrias</surname><given-names>K</given-names></name><name><surname>Harnick</surname><given-names>DJ</given-names></name><name><surname>Marks</surname><given-names>AR</given-names></name></person-group><article-title>The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling</article-title><source>Proc Natl Acad Sci USA</source><volume>92</volume><fpage>6007</fpage><lpage>6011</lpage><year>1995</year></element-citation></ref>
<ref id="b7-ijmm-30-06-1287"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AA</given-names></name><name><surname>Soloski</surname><given-names>MJ</given-names></name><name><surname>Sharp</surname><given-names>AH</given-names></name><name><surname>Schilling</surname><given-names>G</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><name><surname>Li</surname><given-names>SH</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><article-title>Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor</article-title><source>Science</source><volume>273</volume><fpage>503</fpage><lpage>507</lpage><year>1996</year></element-citation></ref>
<ref id="b8-ijmm-30-06-1287"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugawara</surname><given-names>H</given-names></name><name><surname>Kurosaki</surname><given-names>M</given-names></name><name><surname>Takata</surname><given-names>M</given-names></name><name><surname>Kurosaki</surname><given-names>T</given-names></name></person-group><article-title>Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor</article-title><source>EMBO J</source><volume>16</volume><fpage>3078</fpage><lpage>3088</lpage><year>1997</year></element-citation></ref>
<ref id="b9-ijmm-30-06-1287"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharenberg</surname><given-names>AM</given-names></name><name><surname>Humphries</surname><given-names>LA</given-names></name><name><surname>Rawlings</surname><given-names>DJ</given-names></name></person-group><article-title>Calcium signalling and cell-fate choice in B cells</article-title><source>Nat Rev Immunol</source><volume>7</volume><fpage>778</fpage><lpage>789</lpage><year>2007</year></element-citation></ref>
<ref id="b10-ijmm-30-06-1287"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>deSouza</surname><given-names>N</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Dura</surname><given-names>M</given-names></name><name><surname>McDonald</surname><given-names>TV</given-names></name><name><surname>Marks</surname><given-names>AR</given-names></name></person-group><article-title>A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation</article-title><source>J Cell Biol</source><volume>179</volume><fpage>923</fpage><lpage>934</lpage><year>2007</year></element-citation></ref>
<ref id="b11-ijmm-30-06-1287"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>RL</given-names></name><name><surname>Boehning</surname><given-names>D</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><article-title>Inositol 1,4,5-trisphosphate receptors as signal integrators</article-title><source>Annu Rev Biochem</source><volume>73</volume><fpage>437</fpage><lpage>465</lpage><year>2004</year></element-citation></ref>
<ref id="b12-ijmm-30-06-1287"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><article-title>The inositol 1,4,5-trisphosphate receptors</article-title><source>Cell Calcium</source><volume>38</volume><fpage>261</fpage><lpage>272</lpage><year>2005</year></element-citation></ref>
<ref id="b13-ijmm-30-06-1287"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foskett</surname><given-names>JK</given-names></name><name><surname>White</surname><given-names>C</given-names></name><name><surname>Cheung</surname><given-names>KH</given-names></name><name><surname>Mak</surname><given-names>DO</given-names></name></person-group><article-title>Inositol trisphosphate receptor Ca<sup>2&#x0002B;</sup> release channels</article-title><source>Physiol Rev</source><volume>87</volume><fpage>593</fpage><lpage>658</lpage><year>2007</year></element-citation></ref>
<ref id="b14-ijmm-30-06-1287"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikoshiba</surname><given-names>K</given-names></name></person-group><article-title>IP3 receptor/Ca<sup>2&#x0002B;</sup> channel: from discovery to new signaling concepts</article-title><source>J Neurochem</source><volume>102</volume><fpage>1426</fpage><lpage>1446</lpage><year>2007</year></element-citation></ref>
<ref id="b15-ijmm-30-06-1287"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Fritz</surname><given-names>N</given-names></name><name><surname>Ibarra</surname><given-names>C</given-names></name><name><surname>Uhl&#x000E9;n</surname><given-names>P</given-names></name></person-group><article-title>Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations</article-title><source>Neurochem Res</source><volume>36</volume><fpage>1175</fpage><lpage>1185</lpage><year>2011</year></element-citation></ref>
<ref id="b16-ijmm-30-06-1287"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inokuchi</surname><given-names>J</given-names></name><name><surname>Komiya</surname><given-names>M</given-names></name><name><surname>Baba</surname><given-names>I</given-names></name><name><surname>Naito</surname><given-names>S</given-names></name><name><surname>Sasazuki</surname><given-names>T</given-names></name><name><surname>Shirasawa</surname><given-names>S</given-names></name></person-group><article-title>Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells</article-title><source>J Hum Genet</source><volume>49</volume><fpage>46</fpage><lpage>52</lpage><year>2004</year></element-citation></ref>
<ref id="b17-ijmm-30-06-1287"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>T</given-names></name><name><surname>Miyasaka</surname><given-names>K</given-names></name><name><surname>Koyanagi</surname><given-names>M</given-names></name><name><surname>Tsunoda</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>I</given-names></name><name><surname>Doi</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><etal/></person-group><article-title>Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice</article-title><source>PLoS One</source><volume>4</volume><fpage>e4240</fpage><year>2009</year></element-citation></ref>
<ref id="b18-ijmm-30-06-1287"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyasaka</surname><given-names>K</given-names></name><name><surname>Fujimoto</surname><given-names>T</given-names></name><name><surname>Kawanami</surname><given-names>T</given-names></name><name><surname>Takiguchi</surname><given-names>S</given-names></name><name><surname>Jimi</surname><given-names>A</given-names></name><name><surname>Funakoshi</surname><given-names>A</given-names></name><name><surname>Shirasawa</surname><given-names>S</given-names></name></person-group><article-title>Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice</article-title><source>Pancreas</source><volume>40</volume><fpage>79</fpage><lpage>83</lpage><year>2011</year></element-citation></ref>
<ref id="b19-ijmm-30-06-1287"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>T</given-names></name><name><surname>Koyanagi</surname><given-names>M</given-names></name><name><surname>Baba</surname><given-names>I</given-names></name><name><surname>Nakabayashi</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Sasazuki</surname><given-names>T</given-names></name><name><surname>Shirasawa</surname><given-names>S</given-names></name></person-group><article-title>Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line</article-title><source>J Hum Genet</source><volume>52</volume><fpage>978</fpage><lpage>984</lpage><year>2007</year></element-citation></ref>
<ref id="b20-ijmm-30-06-1287"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>T</given-names></name><name><surname>Machida</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Tsunoda</surname><given-names>T</given-names></name><name><surname>Doi</surname><given-names>K</given-names></name><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>T</given-names></name><etal/></person-group><article-title>KRAS-induced actin-interacting protein is required for the proper localization of inositol 1,4,5-trisphosphate receptor in the epithelial cells</article-title><source>Biochem Biophys Res Commun</source><volume>407</volume><fpage>438</fpage><lpage>443</lpage><year>2011</year></element-citation></ref>
<ref id="b21-ijmm-30-06-1287"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>T</given-names></name><name><surname>Machida</surname><given-names>T</given-names></name><name><surname>Tsunoda</surname><given-names>T</given-names></name><name><surname>Doi</surname><given-names>K</given-names></name><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Kuroki</surname><given-names>M</given-names></name><name><surname>Shirasawa</surname><given-names>S</given-names></name></person-group><article-title>Determination of the critical region of KRAS-induced actin-interacting protein for the interaction with inositol 1,4,5-trisphosphate receptor</article-title><source>Biochem Biophys Res Commun</source><volume>408</volume><fpage>282</fpage><lpage>286</lpage><year>2011</year></element-citation></ref>
<ref id="b22-ijmm-30-06-1287"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>JC</given-names></name><name><surname>Andersson</surname><given-names>N</given-names></name><name><surname>Stappenbeck</surname><given-names>TS</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Molecular characterization of mouse gastric zymogenic cells</article-title><source>J Biol Chem</source><volume>278</volume><fpage>46138</fpage><lpage>46145</lpage><year>2003</year></element-citation></ref>
<ref id="b23-ijmm-30-06-1287"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Hatakeyama</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Makdisi</surname><given-names>J</given-names></name><name><surname>Ender</surname><given-names>C</given-names></name><name><surname>Forte</surname><given-names>JG</given-names></name></person-group><article-title>Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><volume>296</volume><fpage>G185</fpage><lpage>G195</lpage><year>2009</year></element-citation></ref>
<ref id="b24-ijmm-30-06-1287"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname><given-names>ML</given-names></name></person-group><article-title>Gastric exocrine and endocrine secretion</article-title><source>Curr Opin Gastroenterol</source><volume>25</volume><fpage>529</fpage><lpage>536</lpage><year>2009</year></element-citation></ref>
<ref id="b25-ijmm-30-06-1287"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Futatsugi</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>MK</given-names></name><name><surname>Ebisui</surname><given-names>E</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Kitaguchi</surname><given-names>T</given-names></name><etal/></person-group><article-title>IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism</article-title><source>Science</source><volume>309</volume><fpage>2232</fpage><lpage>2234</lpage><year>2005</year></element-citation></ref>
<ref id="b26-ijmm-30-06-1287"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>SH</given-names></name><name><surname>Dantzler</surname><given-names>WH</given-names></name></person-group><article-title>Molecular and cellular physiology of renal organic cation and anion transport</article-title><source>Physiol Rev</source><volume>84</volume><fpage>987</fpage><lpage>1049</lpage><year>2004</year></element-citation></ref>
<ref id="b27-ijmm-30-06-1287"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alrefai</surname><given-names>WA</given-names></name><name><surname>Gill</surname><given-names>RK</given-names></name></person-group><article-title>Bile acid transporters: structure, function, regulation and pathophysiological implications</article-title><source>Pharm Res</source><volume>24</volume><fpage>1803</fpage><lpage>1823</lpage><year>2007</year></element-citation></ref>
<ref id="b28-ijmm-30-06-1287"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname><given-names>S</given-names></name><name><surname>Thrower</surname><given-names>E</given-names></name></person-group><article-title>Molecular and cellular regulation of pancreatic acinar cell function</article-title><source>Curr Opin Gastroenterol</source><volume>25</volume><fpage>466</fpage><lpage>471</lpage><year>2009</year></element-citation></ref>
<ref id="b29-ijmm-30-06-1287"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anzai</surname><given-names>N</given-names></name><name><surname>Jutabha</surname><given-names>P</given-names></name><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Endou</surname><given-names>H</given-names></name></person-group><article-title>Integrated physiology of proximal tubular organic anion transport</article-title><source>Curr Opin Nephrol Hypertens</source><volume>14</volume><fpage>472</fpage><lpage>479</lpage><year>2005</year></element-citation></ref>
<ref id="b30-ijmm-30-06-1287"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernando</surname><given-names>N</given-names></name><name><surname>Wagner</surname><given-names>CA</given-names></name><name><surname>Gisler</surname><given-names>SM</given-names></name><name><surname>Biber</surname><given-names>J</given-names></name><name><surname>Murer</surname><given-names>H</given-names></name></person-group><article-title>PDZ proteins and proximal ion transport</article-title><source>Curr Opin Nephrol Hypertens</source><volume>13</volume><fpage>569</fpage><lpage>574</lpage><year>2004</year></element-citation></ref>
<ref id="b31-ijmm-30-06-1287"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000F4;ne</surname><given-names>B</given-names></name><name><surname>Eggermont</surname><given-names>J</given-names></name></person-group><article-title>PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes</article-title><source>Am J Physiol Cell Physiol</source><volume>288</volume><fpage>C20</fpage><lpage>C29</lpage><year>2005</year></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-ijmm-30-06-1287" position="float">
<label>Figure 1</label>
<caption>
<p>KRAP expression in the mucous cells and the chief cells of the mouse stomach. (A&#x02013;D) Fluorescent confocal images of stomach sections for KRAP (red), filamentous actin (F-actin) with phalloidin (green), and the merged photo. Low magnification images from the pit region to the base region of gastric glands from wild-type (A) or <italic>KRAP</italic>-deficient (B) mice. Asterisk and arrows indicate gastric lumen and muscularis mucosae beneath the base region, respectively. (C) High magnification images of the pit region of gastric glands. Asterisk indicates gastric lumen. (D) High magnification images of the base regions of gastric glands. Asterisks and arrowheads indicate the parietal cells and the apical membranes of the chief cells, respectively. (E) Fluorescent confocal images of the base regions of gastric glands for KRAP (red), ZO-1 (green), and the merged photo. Blue, 4&#x02032;,6-diamidino-2-phenylindole (DAPI) staining; scale bar, 50 <italic>&#x003BC;</italic>m.</p></caption>
<graphic xlink:href="IJMM-30-06-1287-g00.gif"/></fig>
<fig id="f2-ijmm-30-06-1287" position="float">
<label>Figure 2</label>
<caption>
<p>Colocalization of KRAP with IP<sub>3</sub>Rs in the chief cells and the mucous cells of the mouse stomach. (A) Fluorescent confocal images of the base region of gastric glands for KRAP (red), IP<sub>3</sub>R3 (green), and the merged photo. Arrows indicate the apical membranes of the chief cells. (B) Fluorescent confocal images of the pit region of gastric glands for KRAP (red), IP<sub>3</sub>R3 (green), and the merged photo. Arrows indicate the apical membranes of the mucous cells. (C) Fluorescent confocal images of the base region of gastric glands for IP<sub>3</sub>R2 (red), IP<sub>3</sub>R3 (green), and the merged photo. Asterisks and arrow indicate the parietal cells and the apical membranes of the chief cells, respectively. (D) Fluorescent confocal images of the pit region of gastric glands for IP<sub>3</sub>R2 (red), IP<sub>3</sub>R3 (green), and the merged photo. Arrows indicate the apical membranes of the mucous cells. Blue, 4&#x02032;,6-diamidino-2-phenylindole (DAPI) staining; scale bar, 25 <italic>&#x003BC;</italic>m.</p></caption>
<graphic xlink:href="IJMM-30-06-1287-g01.gif"/></fig>
<fig id="f3-ijmm-30-06-1287" position="float">
<label>Figure 3</label>
<caption>
<p>Impaired localization of IP<sub>3</sub>Rs in the <italic>KRAP</italic>-deficient chief cells and the mucous cells. (A and B) Fluorescent confocal images of the base region of gastric glands for IP<sub>3</sub>R3 (red), F-actin with phalloidin (green), and the merged photo from wild-type (WT) (A) or <italic>KRAP</italic>-deficient (KO) (B) mice. Asterisks and arrows indicate the parietal cells and the apical membranes of the chief cells, respectively. (C and D) Fluorescent confocal images of the pit region of gastric glands for IP<sub>3</sub>R3 (red), F-actin (green), and the merged photo from WT (C) or KO (D) mice. Arrows indicate the apical membranes of the mucous cells. (E and F) Fluorescent confocal images of the base region of gastric glands for IP<sub>3</sub>R2 (red), F-actin (green), and the merged photo from WT (E) or KO (F) mice. Asterisks and arrows indicate the parietal cells and the apical membranes of the chief cells, respectively. Blue, 4&#x02032;,6-diamidino-2-phenylindole (DAPI) staining; scale bar, 25 <italic>&#x003BC;</italic>m.</p></caption>
<graphic xlink:href="IJMM-30-06-1287-g02.gif"/></fig>
<fig id="f4-ijmm-30-06-1287" position="float">
<label>Figure 4</label>
<caption>
<p>KRAP expression and its contribution to the localization of IP<sub>3</sub>R1 in the proximal tubules of the mouse kidney. (A and B) Fluorescent confocal images of the proximal tubules of kidney for KRAP (red), F-actin (green), and the merged photo from wild-type (WT) (A) or <italic>KRAP</italic>-deficient (KO) (B) mice. Arrowheads and arrows indicate the basolateral and the apical regions of the proximal tubules, respectively. (C and D) Fluorescent confocal images of the proximal tubules of kidney for IP<sub>3</sub>R1 (green), F-actin (red), and the merged photo from WT (C) or KO (D) mice. Blue, 4&#x02032;,6-diamidino-2-phenylindole (DAPI) staining; scale bar, 25 <italic>&#x003BC;</italic>m.</p></caption>
<graphic xlink:href="IJMM-30-06-1287-g03.gif"/></fig>
<fig id="f5-ijmm-30-06-1287" position="float">
<label>Figure 5</label>
<caption>
<p>KRAP interacts with IP<sub>3</sub>R1 in the kidney and with IP<sub>3</sub>R3 in the stomach. (A) Western blots showing comparable expression levels of IP<sub>3</sub>R1 in the kidney (left) or of IP<sub>3</sub>R3 in the stomach (right) between <italic>KRAP</italic>-deficient (KO) and wild-type (WT) mice. (B) Anti-KRAP (&#x003B1;KRAP) immunoprecipitations were performed using mouse kidneys and stomachs from WT or KO mice, followed by western blotting with anti-KRAP, anti-IP<sub>3</sub>R1, or anti-IP<sub>3</sub>R3 antibodies. total, total lysate;IP, immunoprecipitation; &#x003B1;, anti-.</p></caption>
<graphic xlink:href="IJMM-30-06-1287-g04.gif"/></fig></sec></back></article>
